LV10184B - Method of preparation of medicine in the form of tablets - Google Patents

Method of preparation of medicine in the form of tablets Download PDF

Info

Publication number
LV10184B
LV10184B LVP-93-513A LV930513A LV10184B LV 10184 B LV10184 B LV 10184B LV 930513 A LV930513 A LV 930513A LV 10184 B LV10184 B LV 10184B
Authority
LV
Latvia
Prior art keywords
cmto
pna
cmecb
water
weight
Prior art date
Application number
LVP-93-513A
Other languages
English (en)
Latvian (lv)
Other versions
LV10184A (lv
Inventor
Peter Lloyd Oren
Werner Max Karl Seidler
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of LV10184A publication Critical patent/LV10184A/xx
Publication of LV10184B publication Critical patent/LV10184B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
LVP-93-513A 1987-02-27 1993-06-08 Method of preparation of medicine in the form of tablets LV10184B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1991587A 1987-02-27 1987-02-27

Publications (2)

Publication Number Publication Date
LV10184A LV10184A (lv) 1994-10-20
LV10184B true LV10184B (en) 1995-04-20

Family

ID=21795732

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-513A LV10184B (en) 1987-02-27 1993-06-08 Method of preparation of medicine in the form of tablets

Country Status (26)

Country Link
EP (1) EP0280571B1 (es)
JP (1) JPH082793B2 (es)
KR (1) KR960005140B1 (es)
CN (1) CN1023765C (es)
AR (1) AR243376A1 (es)
AT (1) ATE92309T1 (es)
AU (1) AU604849B2 (es)
CA (1) CA1316110C (es)
CY (1) CY1741A (es)
DE (2) DE3882739T2 (es)
DK (1) DK175620B1 (es)
EG (1) EG18523A (es)
ES (1) ES2044825T3 (es)
GR (1) GR930300027T1 (es)
HK (1) HK125793A (es)
HU (1) HU202747B (es)
IE (1) IE61419B1 (es)
IL (1) IL85538A (es)
LV (1) LV10184B (es)
MX (1) MX10558A (es)
NZ (1) NZ223619A (es)
PH (1) PH24358A (es)
PT (1) PT86831B (es)
RU (1) RU1831337C (es)
UA (1) UA18251A (es)
ZA (1) ZA881301B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
CA2082156A1 (en) * 1990-05-04 1991-11-05 Amnon Sintov Colonic drug delivery system
FR2667242B1 (fr) * 1990-09-28 1994-11-25 Rhone Poulenc Sante Nouvelles formes orales a liberation prolongee avec un temps de latence au niveau stomacal amoindri.
IT1250654B (it) * 1991-07-08 1995-04-21 Farcon Ag Metodo per la preparazione di forme farmaceutiche orali a rilascio prolungato contenenti sostanze attive a solubilita' dipendente dal valore di ph.
JP2864737B2 (ja) * 1993-10-22 1999-03-08 株式会社ツムラ 徐放性製剤用基剤並びに徐放性製剤及び該製剤の製造方法
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system
EP0906089B1 (en) * 1996-05-13 2003-08-27 Novartis Consumer Health S.A. Buccal delivery system
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
WO1999044614A1 (en) * 1998-03-03 1999-09-10 Daewoong Pharmaceutical Co., Ltd. Pharmaceutical composition containing cefuroxime axetil stable for moisture absorption
KR100296413B1 (ko) * 1998-04-01 2001-11-14 김선진 세파클러함유서방성정제
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
ES2306646T3 (es) * 1999-02-09 2008-11-16 Pfizer Products Inc. Composiciones de farmacos basicos con biodisponibilidad incrementada.
KR100647901B1 (ko) * 1999-07-09 2006-11-17 보령제약 주식회사 세파클러-함유 서방성 약제조성물 및 그의 제조방법
AT500063A1 (de) * 1999-11-23 2005-10-15 Sandoz Ag Beschichtete tablettenkerne
ES2280270T3 (es) 1999-12-28 2007-09-16 Kimberly-Clark Worldwide, Inc. Sistema indicador dependiente de la utilizacion para articulos absorbentes.
BR0016015B1 (pt) 1999-12-28 2010-12-28 pano de limpeza para desinfetar superfìcies rìgidas e método de formação de um pano de limpeza antimicrobiano para desinfetar superfìcie rìgidas.
US6372252B1 (en) * 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
DE60103299T2 (de) * 2000-10-30 2005-05-12 Lupin Ltd., Mumbai Schnell zerfallende cefuroxim axetil enthaltende arzneizusammensetzung mit verzögerter wirkstoffabgabe
CA2514879C (en) * 2003-01-03 2014-09-16 Shire Laboratories Inc. Two or more enteric materials to regulate drug release
DE102005019458A1 (de) * 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
EP1837020A1 (en) * 2006-03-24 2007-09-26 Bioalliance Pharma Mucosal bioadhesive slow release carrier for delivering active principles
EP2359830B1 (en) 2006-04-26 2012-09-19 Supernus Pharmaceuticals, Inc. Controlled released preparations of oxcarbazepine having sigmoidal release profile
EP2090298A4 (en) * 2006-11-13 2014-02-26 Kyorin Seiyaku Kk METHOD FOR PRODUCING A TABLET WITH DELAYED RELEASE
KR20120003906A (ko) 2009-03-27 2012-01-11 교린 세이야꾸 가부시키 가이샤 염기성 첨가제를 함유하는 매트릭스형 서방성 제제
US20120040008A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
US20120039999A1 (en) * 2010-08-11 2012-02-16 Ashish Chatterji Pharmaceutical compositions of metabotropic glutamate 5 receptor (mglu5) antagonists
CN101912373B (zh) * 2010-08-24 2012-01-04 北京京丰制药有限公司 稳定的头孢克洛分散片及其制备方法
JP6456377B2 (ja) * 2014-06-10 2019-01-23 ライオン株式会社 清酒酵母を含有する錠剤
JP7426685B2 (ja) * 2018-06-14 2024-02-02 株式会社東洋新薬 錠剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151913B (es) * 1980-01-11 1983-09-03 Boots Co Ltd
JPS6024765B2 (ja) * 1981-11-27 1985-06-14 辰巳化学株式会社 セフアレキシンの持続性製剤の製造方法
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
LU85058A1 (fr) * 1983-10-24 1985-06-19 Pharlyse Comprimes pharmaceutiques a liberation prolongee,leur preparation et leur utilisation
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
US4680323A (en) * 1983-12-01 1987-07-14 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration
JPS61286330A (ja) * 1985-06-11 1986-12-16 Teijin Ltd 経口徐放性製剤
JPS62120315A (ja) * 1985-11-20 1987-06-01 Shin Etsu Chem Co Ltd 経口投与型徐放性錠剤の製造方法

Also Published As

Publication number Publication date
UA18251A (uk) 1997-12-25
PT86831A (pt) 1988-03-01
CN1023765C (zh) 1994-02-16
DK175620B1 (da) 2004-12-27
MX10558A (es) 1993-11-01
AR243376A1 (es) 1993-08-31
AU604849B2 (en) 1991-01-03
GR930300027T1 (es) 1993-05-24
JPS63227519A (ja) 1988-09-21
IL85538A0 (en) 1988-08-31
AU1219388A (en) 1988-09-01
JPH082793B2 (ja) 1996-01-17
EG18523A (en) 1993-04-30
HK125793A (en) 1993-11-19
RU1831337C (ru) 1993-07-30
ES2044825T1 (es) 1994-01-16
DK98088D0 (da) 1988-02-25
EP0280571A2 (en) 1988-08-31
EP0280571A3 (en) 1989-01-04
LV10184A (lv) 1994-10-20
DK98088A (da) 1988-08-28
DE3882739T2 (de) 1994-02-17
CY1741A (en) 1995-02-17
CA1316110C (en) 1993-04-13
PH24358A (en) 1990-06-13
HU202747B (en) 1991-04-29
DE280571T1 (de) 1993-08-12
ATE92309T1 (de) 1993-08-15
IE880545L (en) 1988-08-27
PT86831B (pt) 1992-05-29
ZA881301B (en) 1989-10-25
HUT46531A (en) 1988-11-28
IE61419B1 (en) 1994-11-02
DE3882739D1 (de) 1993-09-16
KR880009639A (ko) 1988-10-04
IL85538A (en) 1991-09-16
KR960005140B1 (ko) 1996-04-22
CN88101062A (zh) 1988-09-07
EP0280571B1 (en) 1993-08-04
ES2044825T3 (es) 1994-11-16
NZ223619A (en) 1990-10-26

Similar Documents

Publication Publication Date Title
LV10184B (en) Method of preparation of medicine in the form of tablets
Kahan Sirolimus: a comprehensive review
Schröder et al. A prospective placebo-controlled double-blind multicenter trial of intravenous streptokinase in acute myocardial infarction (ISAM): long-term mortality and morbidity
Zullo et al. A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication
Neff et al. Ten years of sirolimus therapy in orthotopic liver transplant recipients
AU8136394A (en) Controlled release preparation
ATE214919T1 (de) Arzneimittel zur gesteuerten freisetzung
AU563642B2 (en) Oral antidiabetic composition
CA2170255A1 (en) Pharmaceutical Composition for Immunoenhancement Therapy
JPS61143316A (ja) 安定な錠剤の製造法
SE8009068L (sv) Partiklar av lipoidlosliga substanser, blandningar innefattande sadana partiklar och pa dessa adsorberade biologiskt aktiva substanser liksom even sett for framstellning av sadana blandningar
KR19990064288A (ko) 글루카곤-유사 인슐린 영양성 펩티드
TR199802789T2 (xx) Eksendin analoglar� bunlar�n �retimi i�in y�ntemler ve bunlar� i�eren farmas�tik m�stahzarlar.
George et al. A review of newer treatment approaches for type-2 diabetes: Focusing safety and efficacy of incretin based therapy
CA2351735A1 (en) Engineered cytotoxic ribonuclease
EP0477968A1 (en) Extract from Ginkgo biloba leaves, in particular for intravenous injection or infusion, a method of preparation of the extract and ampoule preparations containing the extract
DE2925009A1 (de) Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
SK42395A3 (en) Pharmaceutical agent for treatment or prevention of insulin-dependent diabetes mellitus, a method of producing and use thereof
WO2017078277A1 (ko) 약물 지속 방출형 나노 입자 및 상기 나노입자로 표면 개질된 췌장소도세포를 포함하는 당뇨병 치료용 약학 조성물
KR100585973B1 (ko) 피복형 제형 단위
HUP0003634A2 (hu) Dioxo-tiazolidin-származékok és szulfonil-karbamid-származékok alkalmazása diabetes kezelésére szolgáló gyógyszerkészítmények előállítására
Waller et al. Running aschool for dictators.'
AU6326094A (en) New medicament aerosol formulation based on fusafungine, a process for its preparation and pharmaceutical compositions containing it
CA2415082A1 (en) Method for formulating healthcare products with enhanced stability
Finegold Anaerobic infections